about
Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune responseIn vitro correction of cystic fibrosis epithelial cell lines by small fragment homologous replacement (SFHR) technique.Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitroRb binding protein Che-1 interacts with Tau in cerebellar granule neurons. Modulation during neuronal apoptosisAnti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signalingDicer expression and localization in post-mitotic neuronsRole of Bcl-2 expression for productive herpes simplex virus 2 replicationGene transfection efficiency of tracheal epithelial cells by DC-chol-DOPE/DNA complexes.Delayed internalization and lack of recycling in a beta2-adrenergic receptor fused to the G protein alpha-subunit.WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulatorsThymosin alpha 1: from bench to bedside.Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma.Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infectionIncreased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression.HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.Thymosin α1 and cancer: action on immune effector and tumor target cells.Thymosin α1 as a stimulatory agent of innate cell-mediated immune response.Gene expression analysis of human epidermal keratinocytes after N-acetyl L-cysteine treatment demonstrates cell cycle arrest and increased differentiation.Historical review on thymosin α1 in oncology: preclinical and clinical experiences.In vitro evaluation of the wound healing activity of Drypetes klainei stem bark extracts.Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations.TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death.Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors.Highly electroconductive multiwalled carbon nanotubes as potentially useful tools for modulating calcium balancing in biological environments.Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication.N-acetyl-l-cysteine fosters inactivation and transfer to endolysosomes of c-Src.Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.Effect of extremely low frequency electromagnetic fields (ELF-EMF) on Kaposi's sarcoma-associated herpes virus in BCBL-1 cells.Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms.Phenotypic and genotypic characteristics of new euploid-diploid lymphoblastoid B cell lines EBV+, normal human bone marrow derived, spontaneously overgrown in vitro.Inhibition of endogenous reverse transcriptase antagonizes human tumor growth.Gap junction channels reconstituted in two closely apposed lipid bilayers.Differentiation of human melanoma cells induced by cyanidin-3-O-beta-glucopyranoside.Suggested role of the Golgi apparatus and endoplasmic reticulum for crucial sites of hepatitis C virus replication in human lymphoblastoid cells infected in vitro.Binding of Clostridium difficile to Caco-2 epithelial cell line and to extracellular matrix proteins.Low cell dosage of lymphoblastoid human cell lines EBV(+) is associated to chronic hepatitis in a minority of inoculated Nu/Nu mice.Thymosin α1 modifies podosome architecture and promptly stimulates the expression of podosomal markers in mature macrophages.Ultrastructural observations of viral particles within hepatitis C virus-infected human B lymphoblastoid cell line.
P50
Q21263126-27264F44-0090-40E1-B392-99222477E720Q24792158-73FA50FD-4FA0-4CAF-9856-43E24CB563BCQ24816361-617E5850-9E84-479A-852E-E01DA26B07C0Q28236466-224CF420-9B99-478C-B911-29AF8B6EB79DQ28581885-F70647EA-D286-4C66-8725-4E0489D15B91Q28582537-43D6085E-5007-44E5-BCF5-553C43F28C4BQ28584938-726F962F-6BDB-41EE-B3C1-D639E3F03FB7Q30734807-5F24DF5A-7D57-4922-A344-DBF1E55CBA4DQ33374405-CE3EB893-0F69-4909-BC26-A560CE451BDFQ33572324-B400BDD6-DD3E-406F-BC05-CB0A2C533AAAQ33777106-237A65B4-9CB3-4FD7-95E4-63EF1E9055C7Q34643499-36E99F5A-87CC-4837-978A-5D70411FD07DQ35615742-F5C164EF-7D41-46AA-9A81-C3720D409F85Q35991632-FFAF7DDB-3976-409C-8AF3-1A80BFFEC54BQ37420160-BE6EE6D8-0B02-486C-A489-8E56A67B918DQ37609891-B583B739-2A9A-4F9A-A79F-7A17E6F63F17Q38050453-5D5BD386-7EEF-4973-9028-6ED8ED853FA1Q38050836-EE55DD90-E7CF-494C-8ADA-DFFEA8C85800Q38519910-AD0930B7-5FBA-45BC-BAF3-30147DDB67F8Q38533742-B8F96094-36E7-47F4-BEAE-F2751D3FD1F9Q38832772-68E36FCF-A990-4239-8C4E-C91BF83F7365Q39037684-6B877D6E-A560-4C11-965C-24F9B4AB792BQ39401950-3A2D47B5-111D-4377-9879-A69462F6ACDAQ39498444-FABFDF82-7EB7-4363-ADBA-AA89FC994317Q39506980-CD899127-A84A-49E8-B5BC-8A1602C993C9Q39514302-F1E32D39-424D-46DC-85E8-2AE096A4BAF9Q39865964-E2C7CC29-1E06-4EE1-882E-BBC0778DF4B3Q39930834-9C712A55-8899-4ADB-81FD-D71C1587759CQ40092434-D2151FD7-C4BC-4F50-A6CD-B9A9CF6792B9Q40341210-5A2764F4-C451-4FE6-81DC-30924D163752Q40416325-6CC37D6C-03EC-41A1-9E6A-26F5C6E0A75FQ40431552-0C4B5E03-53DD-452F-9271-38678ADE001DQ40439570-929C7B09-385D-42C8-870A-9EEA9252459BQ40440139-963DDA4E-019E-4424-A307-A23591982D6AQ40510296-6DD50F61-AD6B-4087-A056-3DAFFEFD9016Q40664915-1CD6FCA6-53CF-49A7-9415-F21D58197AA2Q40740108-8CB23BA9-356E-47EA-9966-85915AB7B3C0Q40762511-F902593B-DA76-4D81-91CC-60355674BB71Q40812029-9AC5A49F-558A-471F-8BE9-B6E6678AF863Q41123041-ADCF4C0E-1114-46A6-AF8B-696882F870EB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annalucia Serafino
@ast
Annalucia Serafino
@en
Annalucia Serafino
@es
Annalucia Serafino
@nl
type
label
Annalucia Serafino
@ast
Annalucia Serafino
@en
Annalucia Serafino
@es
Annalucia Serafino
@nl
prefLabel
Annalucia Serafino
@ast
Annalucia Serafino
@en
Annalucia Serafino
@es
Annalucia Serafino
@nl
P106
P1153
7003832003
P31
P496
0000-0002-1142-4752